REQUEST A DEMO
Total
USD $0.00
Search more companies

Elfin Drugs Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Elfin Drugs Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Elfin Drugs Private Limited is an enterprise located in India, with the main office in Mohali. The company operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on April 25, 2005. The total number of employees is currently 16 (2025). The latest financial highlights indicate a net sales revenue increase of 4.19% in 2025. Over the same period, its total assets grew by 24.37%. In, 2025, the company’s net profit margin decreased by 0.33%.

Legal Address
E-206, Industrial Area, Phase-8-B
Mohali; Punjab; Postal Code: 160055

Contact Details: Purchase the Elfin Drugs Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Elfin Drugs Private Limited report to view the information.
Registered Capital:
Purchase the Elfin Drugs Private Limited report to view the information.
Financial Auditors:
Purchase the Elfin Drugs Private Limited report to view the information.
Incorporation Date:
April 25, 2005
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Elfin Drugs Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
4.19%
Total Operating Revenue
3.79%
Operating Profit
10.96%
EBITDA
14.41%
Net Profit/Loss for the Period
-29.88%
Total Assets
24.37%
Total Equity
3.94%
Operating Profit Margin
0.4%
Net Profit Margin
-0.33%
Return on Equity (ROE)
-1.83%
Debt / Equity
111.4%
Quick Ratio
0.29%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?